PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

464 articles indexed across 24 specialties, each reviewed by a licensed pharmacist before publication.

⭐ Featured free samples

Three of our best full deep-analysis reports: hand-picked, free to read in full, no subscription required.

🔓 Free Sample
Nephrology / Renal Pharmacy ConfirmatoryGrade: Moderate

Finerenone Outperforms Spironolactone for Cardiorenal Protection in Moderate CKD

Published in: American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions · Jul 20, 2026

Finerenone emerges as the safer choice for CKD patients.

Read Free →
🔓 Free Sample
Neurology / Neuropharmacology ConfirmatoryGrade: Low

Tenecteplase Shortens Stroke Treatment and Transfer Times

Published in: JAMA Network Open · Jul 13, 2026

Tenecteplase speeds up stroke thrombolysis compared to alteplase.

Read Free →
🔓 Free Sample
Rheumatology / Immunology ConfirmatoryGrade: Moderate

EULAR 2025 Streamlines Rheumatoid Arthritis DMARD Management to Nine Recommendations

Published in: Annals of the Rheumatic Diseases · Jun 13, 2026

New EULAR guidelines redefine RA management with DMARDs.

Read Free →
Showing 2 from 1 topic.Sort: Newest | Oldest
AHA/ACC/ESC/WHF Release Second Universal Definition of Heart Failure
★ Editor's Pick Consensus Statement Guideline: Heart Failure Practice-changing Grade: Moderate
Walsh MN, Kober L, Sliwa K, et al.
Jun 29, 2026 · Published in: Global Heart

A new universal definition reshapes heart failure management globally.

New AHA/ACC/ADA/ASN Guideline Unifies Cardiovascular-Kidney-Metabolic Syndrome Management
★ Editor's Pick Guideline Guideline: Heart Failure Practice-changing Grade: High
Ndumele CE, Rodriguez F, Dixon DL, et al.
Jun 9, 2026 · Published in: Journal of the American College of Cardiology

New guideline integrates cardiovascular, kidney, and metabolic care.